Jun. 18, 2022
RLX-33
intraperitoneal Relaxin-3/RXFP3 antagonist in vivo efficacy in induced food intake rats models from 19000 compound HTS and opt. J. Med. Chem., May 20, 2022 Research Triangle Institute, Durham, NC
intraperitoneal Relaxin-3/RXFP3 antagonist in vivo efficacy in induced food intake rats models from 19000 compound HTS and opt. J. Med. Chem., May 20, 2022 Research Triangle Institute, Durham, NC